Antonietta Mele

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (51)

• A novel injectable formulation of 6-fluoro-L-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson's disease
  International Journal of Pharmaceutics 2017 DOI: 10.1016/j.ijpharm.2017.01.038
  +Save
• Commentary: A BK (Slo1) channel journey from molecule to physiology
  Frontiers in Pharmacology 2017 DOI: 10.3389/fphar.2017.00188
  +Save
• Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia
  Journal of Cachexia, Sarcopenia and Muscle 2017 DOI: 10.1002/jcsm.12185
  +Save
• Molecular structure and function of big calcium-activated potassium channels in skeletal muscle: Pharmacological perspectives
  Physiological Genomics 2017 DOI: 10.1152/physiolgenomics.00121.2016
  +Save
• Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations
  European Journal of Pharmaceutical Sciences 2017 DOI: 10.1016/j.ejps.2016.10.001
  +Save
• ATP sensitive potassium channels in the skeletal muscle function: Involvement of the KCNJ11(Kir6.2) gene in the determination of mechanical warner bratzer shear force
  Frontiers in Physiology 2016 DOI: 10.3389/fphys.2016.00167
  +Save
• Antiproliferative effects of neuroprotective drugs targeting big Ca2+-activated K+(BK) channel in the undifferentiated neuroblastoma cells
  Current Topics in Pharmacology 2016
  +Save
• Drugs targeting the metabolically regulated ATP-sensitive potassium channels and big calcium-activated potassium channels in skeletal muscles: Pharmacological perspectives and therapeutic use
  Current Topics in Pharmacology 2016
  +Save
• In vivo longitudinal study of rodent skeletal muscle atrophy using ultrasonography
  Scientific Reports 2016 DOI: 10.1038/srep20061
  +Save
• Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery
  Frontiers in Pharmacology 2016 DOI: 10.3389/fphar.2016.00121
  +Save
• An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function
  AGE 2014 DOI: 10.1007/s11357-013-9544-9
  +Save
• Calcium-Activated K Channel Regulates Cell Viability in Hyperkalemic and Hypokalemic Conditions: Implication in the Neuromuscular Disoders
  BIOPHYSICAL JOURNAL 2014
  +Save
• Calcium-Activated K Channel Regulates Cell Viability in Hyperkalemic and Hypokalemic Conditions: Implication in the Neuromuscular Disoders
  BIOPHYSICAL JOURNAL 2014
  +Save
• Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle
  PHARMACOLOGY RESEARCH & PERSPECTIVES 2014 DOI: 10.1002/prp2.28
  +Save
• Dual response of the KATP channels to staurosporine: a novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes
  BIOCHEMICAL PHARMACOLOGY 2014 DOI: 10.1016/j.bcp.2014.06.023
  +Save
• Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II
  CURRENT DIABETES REVIEWS 2014
  +Save
• Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II
  CURRENT DIABETES REVIEWS 2014
  +Save
• Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II
  Current Diabetes Reviews 2014 DOI: 10.2174/1573399810666140918121022
  +Save
• Pharmacovigilance-pharmacological investigations on sulfonylureas and glinides-induced atrophy in skeletal muscle
  FASEB JOURNAL 2014
  +Save
• Pharmacovigilance-pharmacological investigations on sulfonylureas and glinides-induced atrophy in skeletal muscle
  FASEB JOURNAL 2014
  +Save